NCT02203474 A Study of 3 Doses of Tiotropium Hydrofluoralkane (HFA) Breath Actuated Inhaler (BAI), in Patients With Chronic Obstructive Pulmonary Disease Status WITHDRAWN Phase PHASE2
NCT02202616 Prospective Cohort Study for the Real - Life Effectiveness Evaluation of GlycOpyrronium With IndacatERol Combination in the Management of COPD in Canada (POWER Study) Status COMPLETED Phase PHASE4
NCT02196077 Efficacy and Safety Study of PT009, PT008, and PT005 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE2
NCT02195375 Flutiform® Compared With Seretide® in the Treatment of COPD Status COMPLETED Phase PHASE2/PHASE3
NCT02189577 Efficacy and Safety of Glycopyrrolate Bromide of COPD Patients Status COMPLETED Phase PHASE2
NCT02187926 Evaluation of Clinical Effectiveness of Roflumilast in Routine Practice, in Chronic Obstructive Pulmonary Disease (COPD) Patients in Greece Status COMPLETED Phase N/A
NCT02186340 Effects of Inspiratory Muscle Training on Breathing Pattern in Patients With Chronic Obstructive Pulmonary Disease Status COMPLETED Phase NA
NCT02181023 Acute Effect of Aclidinium on Hyperinflation and Ventilation Inhomogeneity in Severe COPD Patients Status COMPLETED Phase PHASE4
NCT02171377 Quadricipital Electrical Stimulation in COPD Patients Rehabilitation Status COMPLETED Phase NA
NCT02161744 Safety, Tolerability and Preliminary Efficacy of Adipose Derive Stem Cells for Patients With COPD Status TERMINATED Phase PHASE1
NCT02156245 Evaluation of the Effects of Eccentric Training on a Cycle Ergometer, Versus Conventional Concentric Training Status COMPLETED Phase NA
NCT02147015 Personalized Variable Versus Fixed Dose Glucocorticoid Therapy in AECOPD Status COMPLETED Phase NA
NCT02143700 Cognitive Status in Chronic Obstructive Pulmonary Disease's Patients Status UNKNOWN Phase N/A
NCT02140892 A Comparison Study of Two Respiratory Physical Therapy Methods and Standard Medical Treatment for Treating COPD Patients During Acute Exacerbation Status UNKNOWN Phase NA